Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-06-21 08:48 Tx date 2024-06-17 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,360
+27,200 vol $3.80 each |
124,400 | |
Filed 2023-06-12 09:30 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
97,200 | |
Filed 2023-06-09 15:50 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
Filed 2023-06-09 15:50 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
97,200 | |
Filed 2022-05-16 14:31 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
70,000 | |
Filed 2021-05-17 15:58 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
Filed 2021-05-14 13:26 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
Filed 2021-05-14 13:26 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
Filed 2021-05-14 13:26 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-04-22 10:06 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-145,425
-5,817 vol $25.00 each |
0 | |
Filed 2019-04-22 10:06 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-47,960 vol |
0 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,514 vol |
5,817 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
47,960 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,597 vol |
4,303 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,448 vol |
2,706 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
1,258 | |
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
1,258 | |
Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
35,970 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
35,970 |